Correlation Between Phathom Pharmaceuticals and ProPhase Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phathom Pharmaceuticals and ProPhase Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phathom Pharmaceuticals and ProPhase Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phathom Pharmaceuticals and ProPhase Labs, you can compare the effects of market volatilities on Phathom Pharmaceuticals and ProPhase Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phathom Pharmaceuticals with a short position of ProPhase Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phathom Pharmaceuticals and ProPhase Labs.

Diversification Opportunities for Phathom Pharmaceuticals and ProPhase Labs

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Phathom and ProPhase is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Phathom Pharmaceuticals and ProPhase Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProPhase Labs and Phathom Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phathom Pharmaceuticals are associated (or correlated) with ProPhase Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProPhase Labs has no effect on the direction of Phathom Pharmaceuticals i.e., Phathom Pharmaceuticals and ProPhase Labs go up and down completely randomly.

Pair Corralation between Phathom Pharmaceuticals and ProPhase Labs

Given the investment horizon of 90 days Phathom Pharmaceuticals is expected to generate 1.03 times more return on investment than ProPhase Labs. However, Phathom Pharmaceuticals is 1.03 times more volatile than ProPhase Labs. It trades about 0.0 of its potential returns per unit of risk. ProPhase Labs is currently generating about -0.1 per unit of risk. If you would invest  1,299  in Phathom Pharmaceuticals on September 1, 2024 and sell it today you would lose (402.00) from holding Phathom Pharmaceuticals or give up 30.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Phathom Pharmaceuticals  vs.  ProPhase Labs

 Performance 
       Timeline  
Phathom Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phathom Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
ProPhase Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProPhase Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Phathom Pharmaceuticals and ProPhase Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phathom Pharmaceuticals and ProPhase Labs

The main advantage of trading using opposite Phathom Pharmaceuticals and ProPhase Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phathom Pharmaceuticals position performs unexpectedly, ProPhase Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProPhase Labs will offset losses from the drop in ProPhase Labs' long position.
The idea behind Phathom Pharmaceuticals and ProPhase Labs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance